failure

Aletheia Capital Endeavours Launches RepIntel, a Campaign-Grade Platform to Accelerate Global Access to Therapies

October 24, 2025 23:37 ET  | Source: RepIntel. New York, New York, USA, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Aletheia…

2 weeks ago

Berlin Heals Welcomes Dr. Eric Fain as New Board Member

Berlin Heals adds MedTech Veteran Dr. Eric Fain to Board of Directors Dr. Fain brings over 35 years of strategic…

2 weeks ago

36-Year-Old Man Given a Second Chance at Life With Advanced Heart Pump

INDORE, India, Oct. 9, 2025 /PRNewswire/ -- At Apollo Rajshree Hospitals, a 36-year-old man with severe heart failure has been successfully…

4 weeks ago

Berlin Heals Holding AG Successfully Completes Enrollment in Phase I of the CMIC-III Less Invasive Study

Completed Enrollment in First-In-Human Phase I study of Less Invasive Approach Expected to Present 6-Month data in 2026 at a…

4 weeks ago

MG 3 receives four stars but suffers rare and serious seat failure in Euro NCAP crash test

LEUVEN, BELGIUM – For decades, MG’s catchy slogan was ‘Safety Fast’ as the British marque traded on sporty cars that…

2 months ago

Berlin Heals Holding AG Successfully Raises Over 5Million USD Round for Advancing New Less Invasive Approaches

ZUG, Switzerland, Sept. 1, 2025 /PRNewswire/ -- Berlin Heals Holding AG, a MedTech company, is developing a novel treatment to…

2 months ago

Landmark Trial Demonstrates Efficacy of Microcurrent Therapy in Heart Failure: C-MIC II Results Published in the European Journal of Heart Failure

ZUG, Switzerland, July 23, 2025 /PRNewswire/ -- Berlin Heals and the C-MIC II Investigators today announced the publication of the C-MIC II…

3 months ago

Texas Cardiac Arrhythmia Institute at St. David’s Medical Center first in U.S. to use FDA-approved novel wireless system to treat cardiac arrhythmias

AUSTIN, Texas, July 21, 2025 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center…

4 months ago

Berlin Heals Announces Publication of Two-Year Clinical Outcomes of Cardiac Microcurrent Therapy in ESC Heart Failure

Study shows sustained improvements in heart failure symptoms and function following long-term C-MIC therapy ZUG, Switzerland, July 16, 2025 /PRNewswire/ -- Berlin…

4 months ago

ERA Congress: Long-term data show sustained efficacy and safety of zigakibart in patients with IgA nephropathy

VIENNA, June 5, 2025 /PRNewswire/ -- New 100-week data from the ongoing Phase 1/2 study of zigakibart, an investigational anti-APRIL monoclonal…

5 months ago